Clinical trial

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

NCT00003151 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00003151
Title Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
Official title A Phase II Clinical Trial of Anti-Helicobacter Pylori Treatment in Endoscopically Diagnosed Low-Grade Localized Gastric Lymphoma
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators University of Glasgow
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lymphoma
Intervention type Dietary Supplement, Drug
Interventions bismuth subcitrate, amoxicillin, clarithromycin, metronidazole hydrochloride, omeprazole, tetracycline hydrochloride
Enrollment 96
Start date Sep 1, 1997
Primary completion Oct 1, 1998
First posted Aug 24, 2004
Last update posted Jul 2, 2012
Countries United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies